Adding Stereotactic Radiation to the Multidisciplinary Armamentarium for Localized Renal Cell Carcinoma: Ready for Primetime? : An Editorial Regarding a Recent 5-Year Efficacy and Safety Report of a Multicenter Cohort of Primary RCC Patients Treated with SABR

Ann Surg Oncol. 2023 Nov;30(12):6947-6949. doi: 10.1245/s10434-023-13755-2. Epub 2023 Jun 19.
No abstract available

Publication types

  • Multicenter Study
  • Editorial

MeSH terms

  • Carcinoma, Renal Cell* / radiotherapy
  • Carcinoma, Renal Cell* / surgery
  • Humans
  • Kidney Neoplasms* / radiotherapy
  • Kidney Neoplasms* / surgery
  • Radiosurgery* / adverse effects